Intestinal titres of anti‐tissue transglutaminase 2 antibodies correlate positively with mucosal damage degree and inversely with gluten‐free diet duration in coeliac disease
Author(s) -
Tosco A.,
Auricchio R.,
Aitoro R.,
Ponticelli D.,
Primario M.,
Miele E.,
Rotondi Aufiero V.,
Discepolo V.,
Greco L.,
Troncone R.,
Maglio M.
Publication year - 2014
Publication title -
clinical & experimental immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 135
eISSN - 1365-2249
pISSN - 0009-9104
DOI - 10.1111/cei.12366
Subject(s) - tissue transglutaminase , antibody , gliadin , gluten free , immunology , coeliac disease , gastroenterology , intestinal mucosa , medicine , biology , gluten , disease , enzyme , pathology , biochemistry
Summary It has always been known that anti‐tissue transglutaminase 2 (anti‐ TG 2) antibodies are produced in the small intestine. Their serum titres correlate with mucosal damage degree and decrease on a gluten‐free diet ( GFD ). We aimed to correlate intestinal anti‐ TG 2 antibodies levels with degree of mucosal damage and GFD duration. Thirty‐four active, 71 potential and 24 CD patients on GFD for at least 2 years were enrolled. Anti‐ TG 2 deposits were detected in intestinal biopsies by double immunofluorescence. Biopsies were cultured for 24 h with medium, and with gliadin peptic tryptic digest ( PTG ) or A‐gliadin peptide 31–43 ( P 31‐43). Anti‐ TG 2 antibodies secreted into supernatants were measured by enzyme‐linked immunosorbent assay ( ELISA) . All active CD patients secreted high titres of anti‐ TG 2 antibodies into culture medium that increased with the worsening of mucosal injury (Spearman's r = 0·71; P < 0·0001). Seventy of 71 potential CD patients and 15 of 24 treated CD patients secreted low titres of anti‐ TG 2 antibodies into supernatants, eight of nine negative treated patients being on GFD for more than 10 years. An inverse correlation between antibody titres and duration of GFD was found, (Spearman's r = −0·52; P < 0·01). All active, 53 of 71 potential and six of 24 treated, CD patients showed anti‐ TG 2 mucosal deposits. Five of six positive treated CD patients had been on GFD for fewer than 6 years and were also positive for secreted anti‐ TG 2. In treated patients, PTG /P31‐43 was not able to induce secretion of anti‐ TG 2 antibodies into culture medium. Measurement of anti‐ TG 2 antibodies in biopsy supernatants proved to be more sensitive than detection by immunofluorescence to reveal their intestinal production. Intestinal anti TG 2 antibodies titres correlated positively with the degree of mucosal damage and inversely with the duration of GFD .
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom